Dataset Information

FAHFAs are detected in postprandial chylomicron and VLDL fractions and can be released from TG estolides by LPL in vitro

ABSTRACT: Fatty acid esters of hydroxy fatty acids (FAHFAs) are bioactive lipids with anti-diabetic and anti-inflammatory effects, but the mechanisms responsible for their transport in blood are not well understood. In this study, we investigated potential serum carriers of FAHFAs. Microscale thermophoresis showed that binding of 9-PAHSA to serum albumin did not support albumin as the dominant carrier under the conditions tested. We therefore turned our attention to lipoproteins and extracellular vesicles, which were isolated from murine serum by density-based ultracentrifugation and characterized by proteomics and lipidomics. Lipidomic analysis revealed that chylomicrons, very-low-density lipoproteins (VLDL), and low-density lipoproteins (LDL) contain both FAHFAs and their storage form, triacylglycerol estolides (TG-EST). In contrast, no FAHFA-containing lipids were detected in serum extracellular vesicles. As a validation case study, we confirmed the presence of TG-EST in postprandial chylomicrons from human volunteers. Functional assays further showed that lipoprotein lipase (LPL), the enzyme that hydrolyzes triacylglycerols during lipoprotein metabolism, releases FAHFAs from TG-EST. LPL exhibited positional selectivity, releasing distinct PAHSA regioisomers with different efficiencies. Together, these results support the interpretation that FAHFA-related lipids are associated with chylomicron, VLDL, and LDL fractions in the postprandial setting and establish LPL-mediated lipolysis as a potential mechanism for the release and distribution of these bioactive lipids in the circulation.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Blood Serum

SUBMITTER: Marek Vrbacky

LAB HEAD: Ondrej Kuda

PROVIDER: PXD078529 | Pride | 2026-06-29

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	PLK309_Dovile_Kuda_mo_plasma_fractions_5x_SN19-9_250620_ConditionSetup.tsv	Tabular
	PLK309_Dovile_Kuda_mo_plasma_fractions_5x_SN19-9_250620_Report_Protein.tsv	Tabular
	PLK309_Dovile_Kuda_mo_plasma_fractions_5x_SN19-9_250620_full.sne	Other
	PLK309_OE480_25cm_250614_FGU19_K01_1-4uL_DIA-FAIMS_90M_60G.raw	Raw
	PLK309_OE480_25cm_250614_FGU19_K02_4-3uL_DIA-FAIMS_90M_60G.raw	Raw

Items per page:

1 - 5 of 9

Publications

FAHFAs are detected in postprandial chylomicron and VLDL fractions and can be released from TG estolides by LPL in vitro.

Milonaityte Dovile D Brejchova Kristyna K Srp Jaroslav J Kudova Eva E Chodounska Hana H Balas Laurence L Durand Thierry T Abumrad Nada A NA Kuda Ondrej O

Journal of lipid research 20260520 6

Fatty acid esters of hydroxy fatty acids (FAHFAs) are bioactive lipids with antidiabetic and anti-inflammatory effects, but the mechanisms responsible for their transport in blood are not well understood. In this study, we investigated potential serum carriers of FAHFAs. Microscale thermophoresis showed that binding of 9-PAHSA to serum albumin did not support albumin as the dominant carrier under the conditions tested. We therefore turned our attention to lipoproteins and extracellular vesicles, ...[more]

PMID: 42155610

Similar Datasets

Project description:Background and Aims: Inflammasome-mediated caspase-1 activity regulates the maturation and release of the pro-inflammatory cytokines interleukin (IL)-1M-CM-^_ and IL-18. Recently, we showed that caspase-1 deficiency strongly reduces high fat diet-induced adiposity although the mechanism is still unclear. We now aimed to elucidate the mechanism by which caspase-1 deficiency reduces modulates resistance to high fat diet-feeding fat accumulation in adipose tissue by focusing on the role of caspase-1 in the regulation of triglyceride (TG)-rich lipoprotein metabolism. Methods: Caspase-1 deficient and wild-type mice (both C57Bl/6 background) were used to determine postprandial TG kinetics, intestinal TG absorption, VLDL-TG production as well as TG clearance, all of which strongly contribute to the supply of TG for storage in adipose tissue. Micro-array and qPCR analysis were used to unravel intestinal and hepatic metabolic pathways involved. Results: Caspase-1 deficiency reduced the postprandial response to an oral lipid load, while tissue specific clearance of TG-rich lipoproteins was not changed. Indeed, an oral olive oil gavage containing [3H]TG revealed that caspase-1 deficiency significantly decreased intestinal chylomicron-TG production and reduced the uptake of [3H]TG-derived FA by liver, muscle, and adipose tissue. Similarly, caspase-1 deficiency reduced the hepatic VLDL-TG production without reducing VLDL-apoB production, despite an elevated hepatic TG content. Pathway analysis revealed that caspase-1 deficiency reduces intestinal and hepatic expression of genes involved in lipogenesis. Conclusions: Absence of caspase-1 reduces assembly and secretion of TG-rich lipoproteins, thereby reducing the availability of TG-derived FA for uptake by peripheral organs including adipose tissue. We anticipate that caspase-1 represents a novel link between innate immunity and lipid metabolism. Keywords: Expression profiling by array Wild-type (WT) and Casp1-null mice were maintained at lab chow. Animals, aged between 14 and 16 weeks (n=3 per genotype), were killed and liver and intestinal segments were removed. Livers were isolated from mice that were fasted over night, whereas intesines were removed from mice 2 hrs after they received an oral lipid load.Total RNA was isolated and subjected to gene expression profiling.

Project description:Cytochrome P450, family 7, subfamily b, polypeptide 1(CYP7B1) is a widely expressed hydroxylase enzyme that may be involved in inactivation of sterols. Using transposon in zygotes, we have generated rats lacking Cyp7b1 expression. Homozygous mutant animals show absence of Cyp7b1 mRNA expression in liver, small intestine, adipose tissue and muscle. Elevated levels of 25-hidroxycholesterol were found in liver of mutant rats. A fat gavage test showed that postprandial hypertriglyceridemia was decreased in homozygotes lacking Cyp7b1 without changes in cholesterol, APOA1 and APOA4 contents of postprandial lipoproteins. In this experimental setting, gene expression analyses of those coding for proteins involved in HDL structure and metabolism revealed that only hepatic Abca1 mRNA expression was significantly decreased. A four-hour fasting had no impact on plasma lipids. However, after prolonged fasting, plasma triglyceride levels in the homozygous mutants were increased about 164 % of wild types. In agreement with this, an increased hepatic secretion of VLDL in fasting rats treated with tyloxapol and absence of low-density receptor protein on the surface of hepatocytes were observed. The decrease in LDLr was not due to decreased mRNA expression but to increased expression of its protease Psck9. These data indicate that CYP7B1 and its metabolite 25-hydroxycholesterol modulates the metabolism of VLDL in liver by decreasing its capture by LDL receptor. In agreement with this, an increased hepatic secretion of VLDL in fasting rats treated with tyloxapol and absence of low-density receptor protein on the surface of hepatocytes were observed. The decrease in LDLr was not due to decreased mRNA expression but to increased expression of its protease Psck9. These data indicate that CYP7B1 and its metabolite 25-hydroxycholesterol modulates the metabolism of VLDL in liver by decreasing its capture by LDL receptor. These observations were partially recovered by exogenous plasmid hydrodinamic injection

Project description:Cytochrome P450 2B6 (CYP2B6) is a sexually dimorphic, anti-obesity CYP enzyme responsible for the metabolism of xeno- and endobiotics, including the metabolism of polyunsaturated fatty acids (PUFAs) into 9-HODE and 9-HOTrE. However, hCYP2B6-Tg mice are sensitive to diet-induced hepatic steatosis despite their resistance to obesity. The purpose of this manuscript was determine if 9-HODE, 9-HOTrE, or other factors contribute to the sexually dimorphic steatosis observed in hCYP2B6-Tg mice. Cyp2b-null mice were injected with either 9-HODE or 9-HOTrE for 2 days then subjected to a fasting period of 20 hours to induce steatosis. Moderately increased serum lipids, especially in females, were observed after 9-HODE (TG, VLDL) and 9-HOTrE (HLD, LDL, cholesterol) treatment. No change in hepatic lipids and few changes in hepatic gene expression were observed in mice treated with either oxylipin, suggesting these oxylipins had little effect or their effects were extrahepatic. Therefore, to further investigate CYP2B6’s role in steatosis, hCYP2B6-Tg and Cyp2b-null mice were subjected to a 20-hour fast and compared. Both male and female hCYP2B6-Tg mice exhibited increased steatosis compared to Cyp2b-null mice. Serum cholesterol, triglycerides, HDL, and VLDL were increased in hCYP2B6-Tg males. Serum triglycerides and VLDL were decreased in hCYP2B6-Tg females, suggesting greater hepatic retention of lipids. Hepatic oxylipin profiles revealed 8 perturbed oxylipins in hCYP2B6-Tg mice and only 1 in males when compared to Cyp2b-null mice. RNA-seq also demonstrated greater effects in females in terms of number of genes and GO terms perturbed. There were only a few overlapping GO terms and lipid metabolic processes was enriched in hCYP2B6-Tg male mice but repressed in hCYP2B6-Tg females compared to Cyp2b-nulls. In conclusion, hCYP2B6-Tg mice are sensitive to steatosis in males and females although the responses are different. In addition, the oxylipins 9-HODE and 9-HOTrE are unlikely to be a major cause of CYP2B6’s pro-steatotic effects.